10th European Breast Cancer Conference
RAI Amsterdam *Amsterdam, NETHERLANDS Visit the Venue to read more
The European Breast Cancer Conference in 2016 (EBCC-10) will take place in the context of very tangible advances that have been made for patients in recent years. These advances have been largely achieved through the successful application of a multidisciplinary approach in the treatment and care of breast cancer.
EBCC is proud to have played its role in driving these advances for breast cancer patients as a unique, dedicated multidisciplinary platform and the largest breast cancer conference outside the US.
This edition of EBCC (EBCC-10) is again firmly based on a holistic vision of breast cancer and brings together scientists, clinicians, patient representatives and health professionals of diverse profiles to tackle key issues facing patients throughout the continuum of the breast cancer journey. The conference programme will provide the latest insights into the areas of prevention, optimal diagnosis, treatment, survivorship, the advance driven by research in all of them so that EBCC again fulfills its mission to accelerate the translation of clinical research into best practice made widely available to patients all over Europe.
EBCC-10 will replicate the highly successful “Multidisciplinary Teams in the Real World” and will have a strong focus on the work of the breast team throughout its programme. Our aim is to strengthen the knowledge of different members of the breast team as well as help ensure the optimal work of the team as a whole. The conference registration fee structure has been designed specifically to support the participation of breast teams.
The conference will again showcase practice-changing new data and provide delegates with the opportunity to discuss it in sessions with innovative, interactive formats.
EBCC-10 will highlight important regulatory developments in Europe. A European Parliament resolution has stipulated that by 2016 member states should have enshrined in law that all breast cancer patients are to be treated in a specialised breast centre or unit. At EBCC-10, we will review the impact this resolution has had so far on the treatment of breast cancer, we will map the status of its implementation and discuss how best to direct our advocacy efforts in 2016 and beyond.
We look forward to welcoming you to Amsterdam on 9 – 11 March 2016: EBCC-10 awaits your active participation. Help us make it our best ever conference!
Conference ChairConference Co-Chair
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
Amsterdam RAI Hotel & Travel Service (RHTS) is part of RAI Amsterdam B.V. and arranges hotel accommodation for many international conferences in Amsterdam. Amsterdam RAI Hotel & Travel. Service has been appointed as the official accommodation agent for the European Breast Cancer Conference 2016 in Amsterdam from March 9 - 11, 2016.
Amsterdam RAI Hotel & Travel Service
PO Box 77777
NL - 1070 MS Amsterdam
Phone: +31 (0)20 549 1927
Fax: +31 (0)20 549 1946
Selection of Hotels
In close consultation with the organization of the European Breast Cancer Conference, Amsterdam RAI Hotel & Travel Service made a wide selection of hotels in Amsterdam for you in the different categories (3- to 5-star). Amsterdam RAI Hotel & Travel Service offers hotels near the Amsterdam RAI, as well as in the historical city centre of Amsterdam. As the demand for hotel rooms will be high during the European Breast Cancer Conference 2016, Amsterdam RAI Hotel & Travel Service has contracted a large amount of rooms. Nevertheless, we suggest that you reserve your hotel room as soon as you know your exact travel dates.
Hotel website for online bookings
Amsterdam RAI Hotel & Travel Service has created a secured hotel website for European Breast Cancer Conference 2016. On this website you can read a comprehensive description of each hotel, including photos, a map of Amsterdam and ‘How to come to the Amsterdam RAI’ and you can book your hotel room online and receive a direct confirmation.
Individual reservations (maximum 9 rooms)
Individual reservations for up to 9 rooms can be made through the fully secured hotel website. A direct confirmation will be sent by email. All individual reservations require a guarantee with a valid credit card. The payment of your stay will be settled in the hotel. Notifications of cancellations and changes can be made online or by emailing the Amsterdam RAI Hotel & Travel Service. Accordingly, an administration fee of EUR 15 per room will be charged. However, if annulment is received within 48 hours prior to the arrival date, the hotel is entitled to charge according to the cancellation policy.
Abstract submission open: 15 August 2015
Abstract submission deadline: 4 November 2015, 21:00 Central European Time
Abstracts submitted after the stipulated deadline will not be considered.
Authors are strongly advised to submit prior to the deadline and avoid unnecessary delays which may affect the standing of their abstract.
In case of any abstract related queries please contact: firstname.lastname@example.org
Abstract Policy and Regulations
Abstracts on case studies will be rejected.
With the submission of an abstract to 10th European Breast Cancer Conference (EBCC-10), the presenting author:
Certifies to be an investigator with substantial involvement in the clinical study presented in the abstract.
Accepts responsibility for the accuracy of the submitted abstract.
Accepts to be the contact person for all correspondence regarding the abstract and inform co-authors of its status.
Confirms that all co-authors are aware of and agree to the content of the abstract and support the data presented.
Warrants that the data and conclusions presented in the abstract have not been presented or published at any meeting of 500 delegates or more prior to the EBCC-10 conference.
Agrees to submit updated data for important large studies presented (in part) at previous meetings. Violation of this policy may result in rejection of the submitted abstract.
Certifies that the information in the abstract is for exclusive presentation in the European Breast Cancer Conference Scientific Programme and will not be presented during the EBCC-10 at any Satellite Symposia.
States that for all studies involving human or animal subjects, permission has been obtained from the relevant regulatory authority and informed consent given where appropriate.
For abstracts containing clinical trial data include: Trial abbreviation; Trial Registry Number or ID background; Objective, Design, Population studied (including sample size), Intervention, Outcome measure (s), Analysis, Trial status, Trial sponsor(s)
Identifies, obtains and discloses any financial interest in products or processes described in the abstract for all abstract authors. This includes stock ownership, membership on an advisory board or board of directors, corporate-sponsored research and other substantive relationships.
Releases the copyright on behalf of all authors, to ECCO and gives permission for the abstract, when selected for presentation, to be published in the European Breast Cancer Conference Abstract book - a European Journal of Cancer Supplement (in electronic format), as well as on the EBCC-10 website.
Trials in Progress abstracts will not be accepted.
Abstract Preparation and Submission
Abstracts must be submitted in good English and carefully proofread to ensure the accuracy of published material. The Scientific Committee reserves the right to reject abstracts submitted in poor English, or may request an immediate revision by the author.
Authors may provide their preference of presentation format: oral, poster or no preference.
Please choose one main topic to categorise.
The Scientific Committee has the authority to re-categorise the abstract.
The title of the abstract should be concise and accurately describe the study undertaken. Do not use non-standard abbreviations and commercial names (generic names only).
Abstracts should be structured to include the following 4 sections:
Background: introductory sentence specifying the purpose of the study
Material and methods: brief description of relevant experimental procedures
Results: summary of the results of the investigation
Conclusions: a statement of the main conclusions
The abstract submission system will not accept abstracts that exceed 2900 characters (including body of the abstract, spaces and one table).
Only one data table is permitted in the body of the abstract. Illustrations and figures are not allowed and will be deleted if submitted.
Abbreviations may be used if standard or if spelled out and defined at the first use (put in parentheses immediately after the first mention of a term or phrase). Compounds should be mentioned with the generic name, in lower cases. Commercial names are admitted in the text, with an ®, and if in brackets following the generic name, i.e. “generic (Commercial ®)”.
No more than 20 authors can be listed with only their institutional affiliation(s), city and country. Mailing addresses and academic degrees should not be mentioned. For co-operative study groups, the name of the group should be used instead of individual institutional affiliations or include the name of the group in the title of the abstract.
An e-mail confirming receipt of the abstract submitted online will be sent to the presenting author within 48 hours. An abstract number will be allocated and should be mentioned for any queries relating to the submitted abstract.
Abstract Selection Process
Abstracts submitted for presentation in the EBCC-10 will be reviewed by an international panel of experts in the field of the subject and will be judged solely on the data submitted. The final decision on the presentation format of all selected abstracts lies at the sole discretion of the Scientific Committee.
The following presentation formats are applicable at the EBCC-10:
The abstract is selected for oral presentation in one of the proffered papers sessions. Abstracts of superior quality can be selected for presentation in a session where discussants will place the research findings into perspective.
Abstracts that have been selected for poster presentation will be displayed on poster boards in a prominent poster viewing area next to the exhibition. The posters will be grouped by topic and displayed for four hours each. A specific time will be devoted to poster viewing to ensure delegates have sufficient opportunity to acquaint themselves with the presented data.
Prominent experts will provide a thematic overview and discuss the findings from selected abstracts chosen for poster presentation. Delegates will be offered an expert review-at-a-glance of the presented findings and will be able to further refine their interest in specific abstracts.
Poster Spotlight Sessions
The Scientific Committee will make a special selection of posters which will be highlighted through short oral presentations followed by moderated discussion. These sessions will facilitate dynamic exchange on selected findings of broad interest.
Submitting an abstract for presentation in the EBCC-10 does not constitute registration for the conference. When selected, abstract presenters must register to attend the European Breast Cancer Conference in Amsterdam
The presenting author will receive a letter with the result of the review and the Scientific Committee’s decision on the abstract by mid December 2015.
ECCO cannot guarantee any request for withdrawal of an abstract that in any way delays the publications. Requests to withdraw abstracts will be accepted until 21 December 2015. After this date, abstracts selected for presentation must be presented. If the presenting author of a selected abstract cannot attend, they should assign a replacement and inform EBCC secretariat of the replacement as soon as possible.
ECCO Contact Information
ECCO - the European CanCer Organisation
Avenue E. Mounier 83
B-1200 Brussels, Belgium
Tel: +32 2 775 02 01
Fax:+32 2 775 02 00